Standard Lithium Ltd. announced that effective immediately Dr. Volker Berl has been appointed as an independent director of the company. Dr. Berl has been a venture builder and an avid serial investor since 2009. He is the Founder, Managing Partner and Chief Executive Officer of New Age Ventures, a venture studio with a portfolio of earlier stage and actively managed investments across healthcare, medical devices, digital health, cleantech, consumer tech, deep tech, applied artificial intelligence, and more. Mr. Berl is well connected in the New York technology investment community, and currently serves as a director for Gaussin S.A. (since 2006), Leaderlease S.A. (since 2015), OrthogenRx Inc. (since 2015), Venock Inc. (since 2017), Emoshape Inc. (since 2020), and Artract Medical Inc. (since 2021). Dr. Berl has held positions with BASF AG in Germany, from 2002 to 2005 in chemical manufacturing and process engineering, and in global new business development for chemical intermediates. In 2006, he was Vice President Equity Research Pharmaceuticals for Deutsche Bank, and Chief Technology Officer for bioscience company Zymes LLC from 2007 to 2009.